Public trial registry of the CCC-Munich

Trial OPTIMA

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
OPTIMA
World
Full title
:

A Phase III, Randomized, Double Blind, Dummy-Controlled Study of ThermoDox (Lyso-Thermosensitive Liposomal Doxorubicin-LTLD) in Hepatocellular Carcinoma (HCC) Using Standardized Radiofrequency Ablation (RFA) Treatment Time ≥ 45 Minutes for Solitary Lesions ≥ 3 cm to ≤ 7 cm)

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik II, Telefon: 089440072791
Indications
Classification Code Description
ICD-10-GM C22.- Bösartige Neubildung der Leber und der intrahepatischen Gallengänge
- Livertumor
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Double blinded
World
Phase
:
III
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2018-12-31 / 2018-12-31
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization
World Principal Investigator Enrico Toni Keine Organisationseinheit angegeben Magnifier